Abstract
The generation of lymphoid tissues during embryogenesis relies on group 3 innate lymphoid cells (ILC3) displaying lymphoid tissue inducer (LTi) activity and expressing the master transcription factor RORγt. Accordingly, RORγt-deficient mice lack ILC3 and lymphoid structures, including lymph nodes (LN). Whereas T-bet affects differentiation and functions of ILC3 postnatally, the role of T-bet in regulating fetal ILC3 and LN formation remains completely unknown. Using multiple mouse models and single-cell analyses of fetal ILCs and ILC progenitors (ILCP), here we identify a key role for T-bet during embryogenesis and show that its deficiency rescues LN formation in RORγt-deficient mice. Mechanistically, T-bet deletion skews the differentiation fate of fetal ILCs and promotes the accumulation of PLZFhi ILCP expressing central LTi molecules in a RORα-dependent fashion. Our data unveil an unexpected role for T-bet and RORα during embryonic ILC function and highlight that RORγt is crucial in counteracting the suppressive effects of T-bet.
Original language | English |
---|---|
Pages (from-to) | 1231–1244 |
Number of pages | 14 |
Journal | Nature Immunology |
Volume | 22 |
Issue number | 10 |
Early online date | 23 Sept 2021 |
DOIs | |
Publication status | Published - Oct 2021 |
Bibliographical note
Acknowledgements:We thank J. Kirsch, T. Kaiser (Flow Cytometry Core Facility, Deutsches Rheuma-Forschungszentrum, Berlin) and K. Lehmann (Deutsches Rheuma-Forschungszentrum) for technical help. We thank M. Babic for precise help with detection of LN phenotypes; H.-R. Rodewald (Division for Cellular Immunology, German Cancer Research Center, Heidelberg, Germany) and J. Zhu (Molecular and Cellular Immunoregulation Unit, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA) for providing Il7rcre and Tbx21-ZsGreen mice, respectively; A. Diefenbach and M. Hepworth for scientific discussion; G. Gasteiger, C. Klose, T. Schüler, D. Hernández, J. Zhu and A. Kruglov for critically reading the paper. Funding came from Deutsche Forschungsgemeinschaft (DFG) grants from the Heisenberg Program nos. (RO3565/1-1), RO3565/2-1, SPP 1937 (RO3565/4-1 and 4-2) to C.R., DFG-SFB TRR241 B02 to C.R and B03 to H.D.C., R.M. Schwiete Foundation to H.D.C., Leibniz-Science Campus Chronic Inflammation and Leibniz-Kooperative Exzellenz K259/2019 to C.R. and INST 335/597-1 FUGG. SPP1937 (HA5354/8-1 and 8-2) and TRR130, TP17 to A.E.H, and the state of Berlin and the ‘European Regional Development Fund’ (ERDF 2014–2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum) to M-F.M.)